CTXR - キティウス・ファ―マシュ―ティカルズ (Citius Pharmaceuticals Inc.) キティウス・ファ―マシュ―ティカルズ

 CTXRのチャート


 CTXRの企業情報

symbol CTXR
会社名 Citius Pharmaceuticals Inc (キティウス・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 Citius Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products adjunctive cancer care and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30 2016 the Company had not generate any revenues.   キティウス・ファ―マシュ―ティカルズは米国の特殊医薬品メ―カ―。抗感染症薬、がん補助療法、処方薬に焦点を置いた治療薬の開発や商品化に従事する。開発中の薬剤には、カテ―テル関連血流感染を対象とした抗菌薬ロックソリュ―ション「Mino-Lok」や、痔核治療での炎症や麻酔痛を軽減するヒドロコルチゾン-リドカイン局所製剤がある。本社所在地はニュ―ジャ―ジ―州。   Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.
本社所在地 11 Commerce Drive First Floor Cranford NJ 07016 USA
代表者氏名 Leonard L. Mazur Leonard L. Mazur
代表者役職名 Executive Chairman of the Board Secretary
電話番号 +1 908-967-6677
設立年月日 40422
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 7人
url www.citiuspharma.com
nasdaq_url https://www.nasdaq.com/symbol/ctxr
adr_tso
EBITDA EBITDA(百万ドル) -12.52810
終値(lastsale) 1.7899
時価総額(marketcap) 28994216.0109
時価総額 時価総額(百万ドル) 27.69993
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 25.11109
当期純利益 当期純利益(百万ドル) -12.73298
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Citius Pharmaceuticals Inc revenues was not reported. Net loss increased 32% to $9.7M. Higher net loss reflects Research and Development increase of 96% to $4.8M (expense) General and administrative increase of 8% to $4.7M (expense) Gain/Loss on Derivatives - Hedging decrease from $309K (income) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$1.48 to -$1.01.

 CTXRのテクニカル分析


 CTXRのニュース

   Stock with unusually volume activity: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Four Seasons Education (Cayman) Inc. (NYSE:FEDU)  2021/08/25 22:36:46 Stock Equity
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) with the stream of 2.56% also noticed, India Four Seasons Education (Cayman) Inc. (NYSE:FEDU) encountered a rapid change of 0.96% in the last hour of Wednesdays The post Stock with unusually volume activity: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Four Seasons Education (Cayman) Inc. (NYSE:FEDU) appeared first on Stocks Equity .
   Bright Stock Buzz: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Suncor Energy Inc. (NYSE:SU)  2021/08/23 23:43:48 Stock Equity
Citius Pharmaceuticals, Inc. (CTXR) with the stream of 7.55% also noticed, India Suncor Energy Inc. (SU) encountered a rapid change of 4.74% in the last hour of Mondays trading session. The post Bright Stock Buzz: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Suncor Energy Inc. (NYSE:SU) appeared first on Stocks Equity .
   Captivating Stock: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Summit Wireless Technologies, Inc. (NASDAQ:WISA)  2021/08/22 21:37:30 Stock Equity
Citius Pharmaceuticals, Inc. (CTXR) with the stream of 1.72% also noticed, India Summit Wireless Technologies, Inc. (WISA) encountered a rapid change of 4.69% in the last hour of Fridays trading The post Captivating Stock: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Summit Wireless Technologies, Inc. (NASDAQ:WISA) appeared first on Stocks Equity .
   Oscillating Stock: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Seelos Therapeutics, Inc. (NASDAQ:SEEL)  2021/08/17 01:19:43 Stock Equity
Citius Pharmaceuticals, Inc. (CTXR) with the stream of -0.28% also noticed, India Seelos Therapeutics, Inc. (SEEL) encountered a rapid change of 2.24% in the last hour of Mondays trading session. The post Oscillating Stock: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Seelos Therapeutics, Inc. (NASDAQ:SEEL) appeared first on Stocks Equity .
   Analysts Estimate Report : What to Look Out for Citius Pharmaceuticals (NASDAQ:CTXR)  2021/08/12 21:25:00 Stock Market Daily
Earnings results for Citius Pharmaceuticals , Analyst Opinion on Citius Pharmaceuticals , Earnings and Valuation of (NASDAQ:CTXR), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Analysts Estimate Report : What to Look Out for Citius Pharmaceuticals (NASDAQ:CTXR) appeared first on .
   Citius Pharmaceuticals Inc Shares Close the Week 24.7% Higher - Weekly Wrap  2021/04/30 22:30:00 Kwhen Finance
Citius Pharmaceuticals Inc (CTXR) shares closed this week 24.7% higher than it did at the end of last week. The stock is currently up 132.4% year-to-date, up 172.4% over the past 12 months, and down 23.5% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.1%. Trading Activity Shares traded as high as $2.52 and as low as $1.87 this week.Trading volume this week was 16.9% higher than the 10-day average and 102.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 189.3% The company's stock price performance over the past 12 months beats the peer average by 80.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Citius Pharmaceuticals Inc Shares Close the Week 51.5% Higher - Weekly Wrap  2021/02/19 22:30:00 Kwhen Finance
Citius Pharmaceuticals Inc shares closed this week 51.5% higher than it did at the end of last week. The stock is currently up 102.0% year-to-date, up 146.1% over the past 12 months, and down 33.5% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $2.16 and as low as $1.30 this week.Shares closed 5% below its 52-week high and 4e+2% above its 52-week low.Trading volume this week was 42.3% lower than the 10-day average and 79.6% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 17.3% The company's stock price performance over the past 12 months beats the peer average by 23.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Citius Pharmaceuticals Inc Shares Close the Day 32.1% Higher - Daily Wrap  2021/02/19 22:30:00 Kwhen Finance
Citius Pharmaceuticals Inc shares closed today 32.1% higher than it did at the end of yesterday. The stock is currently up 102.0% year-to-date, up 146.1% over the past 12 months, and down 33.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.2%. Trading Activity Shares traded as high as $2.16 and as low as $1.30 this week.Shares closed 5% below its 52-week high and 4e+2% above its 52-week low.Trading volume this week was 42.3% lower than the 10-day average and 79.6% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 17.3% The company's stock price performance over the past 12 months beats the peer average by 23.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Citius Pharmaceuticals Inc Shares Close the Week 24.7% Higher - Weekly Wrap  2021/04/30 22:30:00 Kwhen Finance
Citius Pharmaceuticals Inc (CTXR) shares closed this week 24.7% higher than it did at the end of last week. The stock is currently up 132.4% year-to-date, up 172.4% over the past 12 months, and down 23.5% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.1%. Trading Activity Shares traded as high as $2.52 and as low as $1.87 this week.Trading volume this week was 16.9% higher than the 10-day average and 102.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 189.3% The company's stock price performance over the past 12 months beats the peer average by 80.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Citius Pharmaceuticals Inc Shares Close the Week 51.5% Higher - Weekly Wrap  2021/02/19 22:30:00 Kwhen Finance
Citius Pharmaceuticals Inc shares closed this week 51.5% higher than it did at the end of last week. The stock is currently up 102.0% year-to-date, up 146.1% over the past 12 months, and down 33.5% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $2.16 and as low as $1.30 this week.Shares closed 5% below its 52-week high and 4e+2% above its 52-week low.Trading volume this week was 42.3% lower than the 10-day average and 79.6% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 17.3% The company's stock price performance over the past 12 months beats the peer average by 23.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Citius Pharmaceuticals Inc Shares Close the Day 32.1% Higher - Daily Wrap  2021/02/19 22:30:00 Kwhen Finance
Citius Pharmaceuticals Inc shares closed today 32.1% higher than it did at the end of yesterday. The stock is currently up 102.0% year-to-date, up 146.1% over the past 12 months, and down 33.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.2%. Trading Activity Shares traded as high as $2.16 and as low as $1.30 this week.Shares closed 5% below its 52-week high and 4e+2% above its 52-week low.Trading volume this week was 42.3% lower than the 10-day average and 79.6% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 17.3% The company's stock price performance over the past 12 months beats the peer average by 23.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (医薬品 米国株 キティウス・ファ―マシュ―ティカルズ CTXR Citius Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)